: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

COVID-19: Daily Top 10 Papers

Bladder Cancer, January 2016
Free Subscription

Abstracts
Retrieve all available abstracts of the following 363 articles:
HTML format

Single Articles

WANG YY, Wu ZY, Wang GC, Liu K, et al
LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p.
Tumour Biol. 2016.
Abstract Related articles

YU Y, Li X, Liang C, Tang J, et al
The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis.
Medicine (Baltimore). 2016;95:e4900.
Abstract Related articles

CHEN Z, Wu L, Lin Q, Shi J, et al
Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
Arch Iran Med. 2016;19:645-51.
Abstract Related articles

KEEHN A, Ludmir E, Taylor J, Rabbani F, et al
Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality.
World J Urol. 2016.
Abstract Related articles

SHI J, Fu S, Wang L, Tao Y, et al
Lentivirus-mediated p21/Waf-1 short hairpin RNA enhances the cytotoxic effects and replicative potential of a bladder cancer-specific oncolytic adenovirus in vitro.
Anticancer Drugs. 2016.
Abstract Related articles

KEY J, Dhawan D, Cooper CL, Knapp DW, et al
Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
Int J Nanomedicine. 2016;11:4141-55.
Abstract Related articles

STONE L
Bladder cancer: Two molecular subtypes identified.
Nat Rev Urol. 2016 Sep 13. doi: 10.1038/nrurol.2016.
Abstract Related articles

GUAL FRAU J, Palou J, Rodriguez O, Parada R, et al
Failure of Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder cancer: Definition and treatment options.
Arch Esp Urol. 2016;69:423-33.
Abstract Related articles

KANG M, Ku JH
Liquid biopsy? A recent breakthrough in noninvasive bladder cancer surveillance.
Investig Clin Urol. 2016;57:307-8.
Abstract Related articles

IEDA T, Muto S, Shimizu F, Taguri M, et al
Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia.
EBioMedicine. 2016 Sep 2. pii: S2352-3964(16)30405.
Abstract Related articles

GAISA NT
[Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].
Pathologe. 2016.
Abstract Related articles

DADHANIA V, Zhang M, Zhang L, Bondaruk J, et al
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
EBioMedicine. 2016 Aug 25. pii: S2352-3964(16)30391.
Abstract Related articles

KLAUTKE G
[Radical cystectomy vs. chemoradiation for the treatment of T2-4a N0 M0 bladder cancer].
Strahlenther Onkol. 2016.
Abstract Related articles

ZHOU J, Dong D, Cheng R, Wang Y, et al
Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.
Oncotarget. 2016 Sep 7. doi: 10.18632/oncotarget.11889.
Abstract Related articles

CRITELLI R, Fasanelli F, Oderda M, Polidoro S, et al
Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
Oncotarget. 2016 Sep 7. doi: 10.18632/oncotarget.11883.
Abstract Related articles

KEEHN A, Gartrell B, Schoenberg MP
Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer.
Future Oncol. 2016.
Abstract Related articles

WANG L, Zhou Z, Gong MZ, Pan DL, et al
A Large Bladder Tumor Covered With a Thick "Shell" of Necrotic Material: Misdiagnosis of a Patient With Spina Bifida.
Medicine (Baltimore). 2016;95:e3443.
Abstract Related articles

LUO Y, Zhang X, Mo M, Tan Z, et al
High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
Medicine (Baltimore). 2016;95:e3337.
Abstract Related articles

SAINT-JACQUES N, Lee JS, Brown P, Stafford J, et al
Small-area spatio-temporal analyses of bladder and kidney cancer risk in Nova Scotia, Canada.
BMC Public Health. 2016;16:175.
Abstract Related articles

ZHENG CL, Han XH, Feng SN, Wang JZ, et al
[Value of urine sediment analyzer in the screening of urinary tract infection in cancer patients].
Zhonghua Zhong Liu Za Zhi. 2016;38:35-9.
Abstract Related articles

ARTHUR EG, Arthur GL, Keeler MR, Bryan JN, et al
Risk of Osteosarcoma in Dogs After Open Fracture Fixation.
Vet Surg. 2016;45:30-5.
Abstract Related articles

AGARWAL KK, Roy SG, Kumar R
Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies.
PET Clin. 2016;11:39-46.
Abstract Related articles

SHIMADA K, Fujii T, Tatsumi Y, Anai S, et al
Ubiquilin2 as a novel marker for detection of urothelial carcinoma cells in urine.
Diagn Cytopathol. 2016;44:3-9.
Abstract Related articles

XIAO D, Zhang G, Liu Y, Yang Z, et al
3D detection and extraction of bladder tumors via MR virtual cystoscopy.
Int J Comput Assist Radiol Surg. 2016;11:89-97.
Abstract Related articles

BROOKS M, Mo Q, Krasnow R, Ho PL, et al
Positive association of collagen type I with non-muscle invasive bladder cancer progression.
Oncotarget. 2016 Sep 17. doi: 10.18632/oncotarget.12089.
Abstract Related articles

HAN MH, Lee DS, Jeong JW, Hong SH, et al
Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K/Akt Signaling Pathway.
Drug Dev Res. 2016 Sep 21. doi: 10.1002/ddr.21367.
Abstract Related articles

ROSHDY S, Senbel A, Khater A, Farouk O, et al
Genital Sparing Cystectomy for Female Bladder Cancer and its Functional Outcome; a Seven Years' Experience with 24 Cases.
Indian J Surg Oncol. 2016;7:307-11.
Abstract Related articles

KUPPACHI S, Holanda D, Eberlein M, Alexiev B, et al
An unexpected surge in plasma BKPyV viral load heralds the development of BKPyV associated metastatic bladder cancer in a lung transplant recipient with BKPyV nephropathy.
Am J Transplant. 2016 Sep 20. doi: 10.1111/ajt.14057.
Abstract Related articles

MBEUTCHA A, Shariat SF, Rieken M, Rink M, et al
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
Urol Oncol. 2016 Sep 16. pii: S1078-1439(16)30065.
Abstract Related articles

ANDERSON-OTUNU O, Akhtar S
Chronic Infections of the Urinary Tract and Bladder Cancer Risk: a Systematic Review.
Asian Pac J Cancer Prev. 2016;17:3805-7.
Abstract Related articles

SOLAKHAN M, Demirpence O, Orhan N, Yildirim OA, et al
Lack of Any Role of Systemic Inflammatory Responses in Predicting Muscle Invasion by Bladder Cancer.
Asian Pac J Cancer Prev. 2016;17:3737-9.
Abstract Related articles

DONG BB, Yan JS, Yan YY, Xie TC, et al
Downregulation of Pigment epithelium-derived factor is associated with increased epithelial-mesenchymal transition (EMT) in bladder cancer.
Panminerva Med. 2016.
Abstract Related articles

PAN A, Zhang H, Li Y, Lin TY, et al
Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer.
Nanotechnology. 2016;27:425103.
Abstract Related articles

BRANT A, Kates M, Chappidi MR, Patel HD, et al
Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
Urol Oncol. 2016 Sep 14. pii: S1078-1439(16)30214.
Abstract Related articles

WITJES JA, Dalbagni G, Karnes RJ, Shariat S, et al
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer.
Urol Oncol. 2016 Sep 14. pii: S1078-1439(16)30114.
Abstract Related articles

PECHERY A, Fauconnet S, Bittard H, Lascombe I, et al
Apoptotic effect of the selective PPARbeta/delta agonist GW501516 in invasive bladder cancer cells.
Tumour Biol. 2016.
Abstract Related articles

KOPSIAFTIS S, Sullivan KL, Garg I, Taylor JA, et al
AMPKalpha2 Regulates Bladder Cancer Growth Through SKP2-mediated Degradation of p27.
Mol Cancer Res. 2016 Sep 16. pii: molcanres.0111.2016.
Abstract Related articles

PASSONI N, Gayed B, Kapur P, Sagalowsky AI, et al
Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer.
Urol Oncol. 2016 Sep 13. pii: S1078-1439(16)30066.
Abstract Related articles

LEBENTRAU S, May M, Weckermann D, Speck T, et al
[Non-muscle-invasive bladder cancer: Information transfer from the clinic to the doctor's office : Results of a questionnaire study and presentation of a software solution].
Urologe A. 2016.
Abstract Related articles

REXER H, Merseburger A
[Neoadjuvant therapy before radical cystectomy for muscle-invasive bladder cancer].
Urologe A. 2016.
Abstract Related articles

WU TF, Hsu LT, Tsang BX, Huang LC, et al
Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy.
BMC Complement Altern Med. 2016;16:96.
Abstract Related articles

RAGGI D, Miceli R, Sonpavde G, Giannatempo P, et al
Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis.
Ann Oncol. 2016;27:49-61.
Abstract Related articles

MIYAKE M, Hori S, Morizawa Y, Tatsumi Y, et al
CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer.
Neoplasia. 2016;18:636-646.
Abstract Related articles

ZHAO J, Xu W, He M, Zhang Z, et al
Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent copy number variation in IPO11 and prognostic significance of importin-11 overexpression on poor survival.
Oncotarget. 2016 Sep 28. doi: 10.18632/oncotarget.12315.
Abstract Related articles

KAELBERER JB, O'Donnell MA, Mitchell DL, Snow AN, et al
Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival.
Prostate Int. 2016;4:107-12.
Abstract Related articles

POLETAJEW S, Biernacki R, Buraczynski P, Chojnacki J, et al
Patterns of care in patients with muscle-invasive bladder cancer - a retrospective cohort study.
Contemp Oncol (Pozn). 2016;20:341-3.
Abstract Related articles

WANG G, Zhao MJ, Liu YQ, Liu XW, et al
Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.
Oncotarget. 2016 Sep 28. doi: 10.18632/oncotarget.12324.
Abstract Related articles

HUANG J, Chen X, Lin TX
[Strategies for diagnosis and treatment of bladder cancer in precise times].
Zhonghua Wai Ke Za Zhi. 2016;54:734-737.
Abstract Related articles

FRANTZI M, Klimou Z, Makridakis M, Zoidakis J, et al
Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.
Oncotarget. 2016 Sep 23. doi: 10.18632/oncotarget.12218.
Abstract Related articles

GIL D, Ciolczyk-Wierzbicka D, Dulinska-Litewka J, Laidler P, et al
Integrin-linked kinase regulates cadherin switch in bladder cancer.
Tumour Biol. 2016.
Abstract Related articles

JOSEPH N, Choudhury A
Adjuvant Chemotherapy Is More Suitable Than Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Patients Treated With Radical Chemoradiotherapy.
Int J Radiat Oncol Biol Phys. 2016;96:614-6.
Abstract Related articles

VALLO S, Michaelis M, Gust KM, Black PC, et al
Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts.
BMC Res Notes. 2016;9:454.
Abstract Related articles

SANCHEZ A, Wszolek MF, Drumm MR, Niemierko A, et al
The Natural History of Nonmuscle-Invasive Bladder Cancer Recurrences After Complete Response to Combined-Modality Organ-Preserving Therapy for Muscle-Invasive Bladder Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

OJERHOLM EJ, Smith A, Hwang WT, Baumann BC, et al
Neutrophil-to-Lymphocyte Ratio as a Bladder Cancer Biomarker: Assessing Prognostic and Predictive Value in SWOG 8710.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

ROBERTS HJ, Krasnow RE, Drumm MR, Niemierko A, et al
Clinical Outcomes of Combined Modality Bladder-Sparing Therapy for Patients With Histologic Variants of Bladder Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

ZAGHLOUL MS, Christodouleas JP, Smith A, Abdalla A, et al
Adjuvant Sandwich Chemotherapy and Radiation Versus Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

BLOCK AM, Harkenrider MM, Henry E, Gaynor ER, et al
Concurrent Chemotherapy Improves Overall Survival in Muscle-Invasive Bladder Cancer Patients Undergoing Radiation Therapy: An Analysis of the National Cancer Data Base.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

ZHONG J, Switchenko J, Jegadeesh N, Gillespie TW, et al
Comparison of Outcomes in Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Chemoradiation.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

MOUW K, Braunstein LZ, Kim J, Polak P, et al
Somatic ERCC2 Mutations Are Associated With a Distinct Mutational Signature in Muscle-Invasive Bladder Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

WILLERS H, Liu Q, Efstathiou JA, Gheorghiu L, et al
PARP1 Inhibition Radiosensitizes A Subset Of Genotype-Defined Bladder Cancers Through Modulation Of Reactive Oxygen Species.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

KORPICS M, Block AM, Harkenrider MM, Welsh JS, et al
The Impact of Radiation Therapy Dose on Survival in Patients with Muscle-Invasive Bladder Cancer: A Population-Based Analysis.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

TUANQUIN LC, McDermott D, Mackley HB, Holder S, et al
The Outcomes of Adjuvant Radiation Therapy in Postcystectomy Muscle-Invasive Bladder Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

SOLANKI AA, Korpics M, Small C, Harkenrider MM, et al
Variability of Radiation Oncologists' Chemoradiation Therapy Patterns of Care and the Impact of Multidisciplinary Clinics in Muscle-Invasive Bladder Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

FISCHER-VALUCK BW, Green OL, Mutic S, Gay HA, et al
Vector Analysis of Bladder Cancer Patient Setup Utilizing a Magnetic Resonance Image Guided Radiation Therapy (MR-IGRT) System.
Int J Radiat Oncol Biol Phys. 2016;96.
Abstract Related articles

FILONENKO EV, Kaprin AD, Alekseev BY, Apolikhin OI, et al
5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial).
Photodiagnosis Photodyn Ther. 2016 Sep 23. pii: S1572-1000(16)30054.
Abstract Related articles

STONE L
Bladder cancer: Rho-sensitive pathway mediates metastasis.
Nat Rev Urol. 2016 Sep 27. doi: 10.1038/nrurol.2016.
Abstract Related articles

BALDIA PH, Maurer A, Heide T, Rose M, et al
Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup.
Oncotarget. 2016 Sep 22. doi: 10.18632/oncotarget.12198.
Abstract Related articles

SORIA F, Moschini M, Haitel A, Wirth GJ, et al
The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer.
Urol Oncol. 2016 Sep 21. pii: S1078-1439(16)30169.
Abstract Related articles

XIA L, Guzzo TJ
Preoperative Anemia and Low Hemoglobin Level Are Associated With Worse Clinical Outcomes in Patients With Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis.
Clin Genitourin Cancer. 2016 Aug 29. pii: S1558-7673(16)30251.
Abstract Related articles

CAO R, Meng Z, Liu T, Wang G, et al
Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Oncotarget. 2016 Sep 20. doi: 10.18632/oncotarget.12146.
Abstract Related articles

JIN X, Zhang P, Luo L, Cheng H, et al
Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies.
Int J Nanomedicine. 2016;11:4535-4544.
Abstract Related articles

CHEN DJ, Chen W, Jiang H, Yang H, et al
Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition.
Drug Des Devel Ther. 2016;10:2845-2853.
Abstract Related articles

DE PAOLI M, Gogalic S, Sauer U, Preininger C, et al
Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis.
Dis Markers. 2016;2016:4591910.
Abstract Related articles

OGIHARA K, Kikuchi E, Yuge K, Yanai Y, et al
The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking.
Ann Surg Oncol. 2016.
Abstract Related articles

VLAHOU A, Black PC, Goebell PJ, Kamat AM, et al
Taking the next step-Advancing bladder cancer management.
Urol Oncol. 2016;34:435-6.
Abstract Related articles

JENSEN TK, Jensen NV, Jorgensen SM, Clark P, et al
Trends in cancer of the urinary bladder and urinary tract in elderly in Denmark, 2008-2012.
Acta Oncol. 2016;55 Suppl 1:85-90.
Abstract Related articles

YADAV S, Banerjee I, Tomar V, Yadav SS, et al
Pelvic paraganglioma: a rare and unusual clinical presentation of paraganglioma.
BMJ Case Rep. 2016;2016.
Abstract Related articles

CHUNG KT
Carcinogenicity, allergenicity, and lupus-inducibility of arylamines.
Front Biosci (Elite Ed). 2016;8:29-39.
Abstract Related articles

CAO Q, Wang N, Qi J, Gu Z, et al
Long noncoding RNAGAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (CC motif) ligand 1 expression.
Mol Med Rep. 2016;13:27-34.
Abstract Related articles

HUANG YC, Yu HS, Chai CY
Aldehyde dehydrogenase induction in arsenic-exposed rat bladder epithelium.
Exp Toxicol Pathol. 2016;68:61-8.
Abstract Related articles

GERSHMAN B, Moreira DM, Tollefson MK, Frank I, et al
The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Urol Oncol. 2016;34:4.
Abstract Related articles

HAYASHI T, Yuasa T, Uehara S, Inoue Y, et al
Clinical outcome of urachal cancer in Japanese patients.
Int J Clin Oncol. 2016;21:133-8.
Abstract Related articles

LIU Y, Yang W, Zhao L, Liang Z, et al
Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis.
BMC Immunol. 2016;17:36.
Abstract Related articles

PALMER S, Litvinova K, Dunaev A, Yubo J, et al
Optical redox ratio and endogenous porphyrins in the detection of urinary bladder cancer: A patient biopsy analysis.
J Biophotonics. 2016 Oct 7. doi: 10.1002/jbio.201600162.
Abstract Related articles

PRASAIN JK, Rajbhandari R, Keeton AB, Piazza GA, et al
Metabolism and growth inhibitory activity of cranberry derived flavonoids in bladder cancer cells.
Food Funct. 2016;7:4012-4019.
Abstract Related articles

YANG Y, Deng S, Zeng Q, Hu W, et al
Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.
Dalton Trans. 2016.
Abstract Related articles

LI XZ, Han Y, Tian J, Ren X, et al
Enhancement of dendritic cells with melanoma-associated antigen 3 for inducing cytotoxicity by cytotoxic T lymphocytes on bladder cancer BIU-87 cells.
Genet Mol Res. 2016;15.
Abstract Related articles

CHOI BH, Lee DH, Kim J, Kang JH, et al
Controls of Nuclear Factor-Kappa B Signaling Activity by 5'-AMP-Activated Protein Kinase Activation With Examples in Human Bladder Cancer Cells.
Int Neurourol J. 2016;20:182-187.
Abstract Related articles

HIRASAWA Y, Nakashima J, Yunaiyama D, Sugihara T, et al
Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Ann Surg Oncol. 2016.
Abstract Related articles

ZHOU J, Duan H, Xie Y, Ning Y, et al
MiR-193a-5p Targets the Coding Region of AP-2alpha mRNA and Induces Cisplatin Resistance in Bladder Cancers.
J Cancer. 2016;7:1740-1746.
Abstract Related articles

MATSUMOTO R, Tsuda M, Yoshida K, Tanino M, et al
Aldo-keto reductase 1C1 induced by interleukin-1beta mediates the invasive potential and drug resistance of metastatic bladder cancer cells.
Sci Rep. 2016;6:34625.
Abstract Related articles

CLARK PE, Spiess PE, Agarwal N, Bangs R, et al
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.
J Natl Compr Canc Netw. 2016;14:1213-1224.
Abstract Related articles

JANG D, Lim CS, Shin YS, Ko YK, et al
A comparison of regional and general anesthesia effects on 5 year survival and cancer recurrence after transurethral resection of the bladder tumor: a retrospective analysis.
BMC Anesthesiol. 2016;16:16.
Abstract Related articles

FALTAS B, Goldenberg DM, Ocean AJ, Govindan SV, et al
Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma.
Clin Genitourin Cancer. 2016;14:e75-9.
Abstract Related articles

ADEJORO O, Alishahi A, Soubra A, Konety B, et al
Trends in PET Scan Usage for Imaging of Patients Diagnosed With Nonmetastatic Urologic Cancer.
Clin Genitourin Cancer. 2016;14:38-47.
Abstract Related articles

PALAZZETTI A, Oderda M, Falcone M, Cassenti A, et al
Osteoclast-Like Giant Cell Carcinoma Hidden by a Bladder Stone in a Patient With Neurogenic Bladder.
Clin Genitourin Cancer. 2016;14:e127-30.
Abstract Related articles

POKURI VK, Syed JR, Yang Z, Field EP, et al
Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.
Clin Genitourin Cancer. 2016;14:e59-65.
Abstract Related articles

WYMER KM, Antic T, O'Donnell PH
Case Report of a Rare Presentation of Urothelial Carcinoma With Gastric Metastasis.
Clin Genitourin Cancer. 2016;14:e111-4.
Abstract Related articles

KIM YS, Lee SI, Park SH, Park S, et al
A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma.
Clin Genitourin Cancer. 2016;14:76-81.
Abstract Related articles

WINTERS BR, Bremjit PJ, Gore JL, Lin DW, et al
Preliminary Comparative Effectiveness of Robotic Versus Open Radical Cystectomy in Elderly Patients.
J Endourol. 2016;30:212-7.
Abstract Related articles

ZARGAR-SHOSHTARI K, Sverrisson EF, Sharma P, Gupta S, et al
Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
Clin Genitourin Cancer. 2016;14:82-8.
Abstract Related articles

PINCIROLI P, Won H, Iyer G, Canevari S, et al
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma.
Clin Genitourin Cancer. 2016;14:e81-90.
Abstract Related articles

WANG J, Chen X, Liu Y, Chen J, et al
Cystic Angiomyolipomas in the Bladder: A Case Report With Imaging Findings and Review of the Literature.
Clin Genitourin Cancer. 2016;14:e99-e102.
Abstract Related articles

KANG M, Jeong CW, Kwak C, Kim HH, et al
The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
Ann Surg Oncol. 2016;23:335-42.
Abstract Related articles

UCER O, Albaz AC, Atag E, Karaoglu A, et al
The Rate of Neoadjuvant Chemotherapy Use in Muscle Invasive Bladder Cancer and The Approach of Urologists in Turkey.
Urol J. 2016;13:2841-2844.
Abstract Related articles

YOSHIDA T, Kinoshita H, Fukui K, Matsuzaki T, et al
Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Ann Surg Oncol. 2016.
Abstract Related articles

MAK KS, Smith AB, Eidelman A, Clayman R, et al
Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
Int J Radiat Oncol Biol Phys. 2016 Aug 24. pii: S0360-3016(16)33135.
Abstract Related articles

KUMONDAI M, Hosono H, Orikasa K, Arai Y, et al
CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers.
Biol Pharm Bull. 2016;39:1683-1686.
Abstract Related articles

RESHETNIKOVA G, Sidorenko VS, Whyard T, Lukin M, et al
Genotoxic and cytotoxic effects of the environmental pollutant 3-nitrobenzanthrone on bladder cancer cells.
Exp Cell Res. 2016 Oct 5. pii: S0014-4827(16)30318.
Abstract Related articles

LAURENT M, Brureau L, Demery ME, Flechon A, et al
Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study.
Urol Oncol. 2016 Oct 6. pii: S1078-1439(16)30211.
Abstract Related articles

MOSCHINI M, Luzzago S, Zaffuto E, Dell'Oglio P, et al
The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience.
Eur J Surg Oncol. 2016 Sep 28. pii: S0748-7983(16)30897.
Abstract Related articles

CAFFO O, Thompson C, De Santis M, Kragelj B, et al
Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials.
Radiother Oncol. 2016 Oct 5. pii: S0167-8140(16)34304.
Abstract Related articles

ZHUO Y, Chen Q, Chen B, Zhan X, et al
Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest.
Int J Clin Pharmacol Ther. 2016.
Abstract Related articles

ORYWAL K, Jelski W, Werel T, Szmitkowski M, et al
The activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in the sera of bladder cancer patients.
Acta Biochim Pol. 2016.
Abstract Related articles

GOODISON S, Ogawa O, Matsui Y, Kobayashi T, et al
A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.
J Transl Med. 2016;14:287.
Abstract Related articles

WAKABAYASHI Y, Iwaya M, Akita M, Takeuchi W, et al
Pulmonary Tumor Thrombotic Microangiopathy Caused by Urothelial Carcinoma Expressing Vascular Endothelial Growth Factor, Platelet-derived Growth Factor, and Osteopontin.
Intern Med. 2016;55:651-6.
Abstract Related articles

OHTAKA M, Kawahara T, Kumano Y, Maeda Y, et al
Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report.
J Med Case Rep. 2016;10:48.
Abstract Related articles

NAWAR NA, Olsen J, Jelic TM, He C, et al
Primary Urinary Bladder Angiosarcoma with Osteoclast-Like Multinucleated Giant Cells: A Case Report and Literature Review.
Am J Case Rep. 2016;17:143-9.
Abstract Related articles

PATRIARCA C, Hurle R, Moschini M, Freschi M, et al
Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.
Diagn Pathol. 2016;11:6.
Abstract Related articles

FUKUMOTO K, Kikuchi E, Mikami S, Miyajima A, et al
Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guerin.
BMC Urol. 2016;16:5.
Abstract Related articles

CHEN Y, Hong C, Ning Y, Su X, et al
Meta-analysis of studies with bivariate binary outcomes: a marginal beta-binomial model approach.
Stat Med. 2016;35:21-40.
Abstract Related articles

WANG QH, Ji ZG, Li HZ, Fan H, et al
Clinicopathologic Comparison of Urothelial Bladder Carcinoma in Young and Elder Patients.
Pathol Oncol Res. 2016;22:67-70.
Abstract Related articles

WANG F, Wu D, He F, Fu H, et al
Study on the significance of Cofilin 1 overexpression in human bladder cancer.
Tumori. 2016 Oct 21:0. doi: 10.5301/tj.5000569.
Abstract Related articles

COLOMBO R, van Valenberg H, Moschini M, Witjes JA, et al
Radiofrequency-induced thermo-chemotherapy effect (RITE) for non muscle invasive bladder cancer treatment: current role and perspectives.
Urologia. 2016;83.
Abstract Related articles

LIN F, Dong L, Wang W, Liu Y, et al
An Efficient Light-Inducible P53 Expression System for Inhibiting Proliferation of Bladder Cancer Cell.
Int J Biol Sci. 2016;12:1273-1278.
Abstract Related articles

PARK S, Fudhaili A, Oh SS, Lee KW, et al
Cytotoxic effects of kazinol A derived from Broussonetia papyrifera on human bladder cancer cells, T24 and T24R2.
Phytomedicine. 2016;23:1462-1468.
Abstract Related articles

CHENG HP, Liu Q, Li Y, Li XD, et al
The inhibitory effect of PDIA6 downregulation on bladder cancer cell proliferation and invasion.
Oncol Res. 2016.
Abstract Related articles

DOGAN HS, Bozaci AC, Ozdemir B, Tonyali S, et al
Ureteroneocystostomy in primary vesicoureteral reflux: critical retrospective analysis of factors affecting the postoperative urinary tract infection rates.
Int Braz J Urol. 2014.
Abstract Related articles

CESARIO JM, Brito RB, Malta CS, Silva CS, et al
A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells.
In Vitro Cell Dev Biol Anim. 2016.
Abstract Related articles

ZERMANN DH, Vahlensieck W, Hoffmann W
[Erratum to: Social medical/public health assessment of bladder cancer after curative and adjuvant therapy].
Urologe A. 2016.
Abstract Related articles

KRAL M, Michalek J, Skarda J, Tichy T, et al
High-grade urothelial bladder cancer in children: A case report and critical analysis of the literature.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016.
Abstract Related articles

ANDREU Z, Oshiro RO, Redruello A, Lopez-Martin S, et al
Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431.
Abstract Related articles

MEEKS JJ, Carneiro BA, Pai SG, Oberlin DT, et al
Genomic characterization of high-risk non-muscle invasive bladder cancer.
Oncotarget. 2016 Oct 14. doi: 10.18632/oncotarget.12661.
Abstract Related articles

PEREIRA PM, Silva S, Bispo M, da Rocha Zuzarte M, et al
Preclinical study on mitochondria-targeted photodynamic therapy using a galactodendritic chlorin for bladder cancer.
Bioconjug Chem. 2016.
Abstract Related articles

ZHAO M, Yu S, Zhang M
Differential expression of multidrug resistancerelated proteins in adriamycinresistant (pumc91/ADM) and parental (pumc91) human bladder cancer cell lines.
Mol Med Rep. 2016 Oct 5. doi: 10.3892/mmr.2016.5806.
Abstract Related articles

KAMIYA N, Suzuki H, Suyama T, Kobayashi M, et al
Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
Int J Clin Oncol. 2016.
Abstract Related articles

ZHI Y, Pan J, Shen W, He P, et al
Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p.
Cell Physiol Biochem. 2016;39:1787-1794.
Abstract Related articles

MORALES-BARRERA R, Suarez C, de Castro AM, Racca F, et al
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
Cancer Treat Rev. 2016;50:208-216.
Abstract Related articles

ROSENBLATT R, Johansson M, Alamdari F, Sidiki A, et al
Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report.
World J Urol. 2016.
Abstract Related articles

CHEN M, Rothman N, Ye Y, Gu J, et al
Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development.
Genes Cancer. 2016;7.
Abstract Related articles

TAKAOKA EI, Miyazaki J, Ishikawa H, Kawai K, et al
Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer.
Jpn J Clin Oncol. 2016.
Abstract Related articles

HEIDEGGER I, Tulchiner G, Schafer G, Horninger W, et al
Long term disease free survival with multimodal therapy in small cell bladder cancer.
Eur J Med Res. 2016;21:40.
Abstract Related articles

DURAN I, Hagen C, Arranz JA, Apellaniz-Ruiz M, et al
SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma.
Pharmacogenomics. 2016;17:463-71.
Abstract Related articles

BERNARDES FILHO F, de Melo AS, Pires AR, Lupi O, et al
Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical and dermatopathologic features.
An Bras Dermatol. 2016;91:73-9.
Abstract Related articles

BAZRAFSHANI MR, Nowshadi PA, Shirian S, Daneshbod Y, et al
Deletion/duplication mutation screening of TP53 gene in patients with transitional cell carcinoma of urinary bladder using multiplex ligation-dependent probe amplification.
Cancer Med. 2016;5:145-52.
Abstract Related articles

GEYNISMAN DM, Handorf E, Wong YN, Doyle J, et al
Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma.
Cancer Med. 2016;5:192-9.
Abstract Related articles

PARK S, Cho MS, Kim KH
A case report of urothelial carcinoma with combined micropapillary and plasmacytoid morphology in the urinary bladder.
Diagn Cytopathol. 2016;44:124-7.
Abstract Related articles

YOUNES I, Frachet V, Rinaudo M, Jellouli K, et al
Cytotoxicity of chitosans with different acetylation degrees and molecular weights on bladder carcinoma cells.
Int J Biol Macromol. 2016;84:200-7.
Abstract Related articles

DUAN W, Du L, Jiang X, Wang R, et al
Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
Oncotarget. 2016 Oct 25. doi: 10.18632/oncotarget.12880.
Abstract Related articles

HONG X, Li T, Ling F, Yang D, et al
Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis.
Oncotarget. 2016 Oct 25. doi: 10.18632/oncotarget.12907.
Abstract Related articles

HONG Z, Wu J, Li Q, Zhang S, et al
Meta-analysis reveals no significant association between ERCC6 polymorphisms and bladder cancer risk.
Int J Biol Markers. 2016 Oct 22:0. doi: 10.5301/jbm.5000236.
Abstract Related articles

HAU AM, Leivo MZ, Gilder AS, Hu JJ, et al
mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer.
Cell Signal. 2016;29:96-106.
Abstract Related articles

ZHUO C, Li X, Zhuang H, Tian S, et al
Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysis.
Oncotarget. 2016 Oct 24. doi: 10.18632/oncotarget.12856.
Abstract Related articles

SARGOS P, Baumann BC, Eapen LJ, Bahl A, et al
Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
Transl Androl Urol. 2016;5:702-710.
Abstract Related articles

KLAILE Y, Schlack K, Boegemann M, Steinestel J, et al
Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?
Transl Androl Urol. 2016;5:692-701.
Abstract Related articles

SORIA F, Moschini M, Korn S, Shariat SF, et al
How to optimally manage elderly bladder cancer patients?
Transl Androl Urol. 2016;5:683-691.
Abstract Related articles

MARKS P, Soave A, Shariat SF, Fajkovic H, et al
Female with bladder cancer: what and why is there a difference?
Transl Androl Urol. 2016;5:668-682.
Abstract Related articles

SMOLENSKY D, Rathore K, Cekanova M
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer.
Drug Des Devel Ther. 2016;10:3305-3322.
Abstract Related articles

EARL J, Rico D, Carrillo-de-Santa-Pau E, Rodriguez-Santiago B, et al
Erratum to: The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.
BMC Genomics. 2016;17:829.
Abstract Related articles

ZHANG Y, Nolan M, Yamada H, Watanabe M, et al
Dynamin2 GTPase contributes to invadopodia formation in invasive bladder cancer cells.
Biochem Biophys Res Commun. 2016 Oct 19. pii: S0006-291X(16)31741.
Abstract Related articles

ALFANO M, Nebuloni M, Allevi R, Zerbi P, et al
Linearized texture of three-dimensional extracellular matrix is mandatory for bladder cancer cell invasion.
Sci Rep. 2016;6:36128.
Abstract Related articles

WANG G, Cao R, Wang Y, Qian G, et al
Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARgamma signalling pathway.
Sci Rep. 2016;6:35783.
Abstract Related articles

ARRUDA RP, Mariano MB, Pereira CF, Lima GC, et al
Laparoscopic Cystoprostatectomy for Bladder Cancer in a Male patient combined with open ileal conduit urinary diversion.
Int Braz J Urol. 2016 Oct 25. doi: 10.1590/S1677-5538.IBJU.2014.0632.
Abstract Related articles

QI D, Li J, Que B, Su J, et al
Long non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancer.
Cancer Cell Int. 2016;16:81.
Abstract Related articles

SINGH P, Black P
Emerging role of checkpoint inhibition in localized bladder cancer.
Urol Oncol. 2016 Oct 21. pii: S1078-1439(16)30272.
Abstract Related articles

ROSENKRANTZ AB, Friedman KP, Ponzo F, Raad RA, et al
Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.
Clin Nucl Med. 2016.
Abstract Related articles

QIAN K, Wang G, Cao R, Liu T, et al
Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways.
Molecules. 2016;21.
Abstract Related articles

STARKOV KE, Bunimovich-Mendrazitsky S
Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy.
Math Biosci Eng. 2016;13:1059-1075.
Abstract Related articles

SADEE C, Kashdan E
A model of thermotherapy treatment for bladder cancer.
Math Biosci Eng. 2016;13:1169-1183.
Abstract Related articles

SKOWRON KB, Pitroda SP, Namm JP, Balogun O, et al
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.
Sci Rep. 2016;6:35854.
Abstract Related articles

NOSSIER AI, Mohammed OS, Fakhr El-Deen RR, Zaghloul AS, et al
Gelatin-modified gold nanoparticles for direct detection of urinary total gelatinase activity: Diagnostic value in bladder cancer.
Talanta. 2016;161:511-519.
Abstract Related articles

FERREIRA-TEIXEIRA M, Paiva-Oliveira D, Parada B, Alves V, et al
Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
BMC Med. 2016;14:163.
Abstract Related articles

HUANG HH, Kuo SM, Wu YJ, Su JH, et al
Improvement and enhancement of antibladder carcinoma cell effects of heteronemin by the nanosized hyaluronan aggregation.
Int J Nanomedicine. 2016;11:1237-51.
Abstract Related articles

BACON N, Souza CH, Franz S
Total cysto-prostatectomy: Technique description and results in 2 dogs.
Can Vet J. 2016;57:141-6.
Abstract Related articles

SOKOLOV A, Paull EO, Stuart JM
ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES.
Pac Symp Biocomput. 2016;21:405-16.
Abstract Related articles

ZHANG Y, Wang X, Hoffman RM, Seki N, et al
Real Time Metastatic Route Tracking of Orthotopic PC-3-GFP Human Prostate Cancer Using Intravital Imaging.
J Cell Biochem. 2016;117:1027-32.
Abstract Related articles

PIETRUSINSKI M, Kepczynski, Jedrzejczyk A, Borkowska E, et al
Detection of bladder cancer in urine sediments by a hypermethylation panel of selected tumor suppressor genes.
Cancer Biomark. 2016.
Abstract Related articles

GARCIA J, Santome L, Anido U, Fernandez-Calvo O, et al
Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).
Curr Oncol Rep. 2016;18:72.
Abstract Related articles

SCARPA ES, Emanuelli M, Frati A, Pozzi V, et al
Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells.
Food Funct. 2016.
Abstract Related articles

JIN X, Ma J, Liang X, Tang K, et al
Pre-instillation of tumor microparticles enhances intravesical chemotherapy of nonmuscle-invasive bladder cancer through a lysosomal pathway.
Biomaterials. 2016;113:93-104.
Abstract Related articles

DONG D, Jiang W, Lei J, Chen L, et al
Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.
Oncotarget. 2016 Oct 28. doi: 10.18632/oncotarget.12976.
Abstract Related articles

MANDAIR GS, Han AL, Keller ET, Morris MD, et al
Raman microscopy of bladder cancer cells expressing green fluorescent protein.
J Biomed Opt. 2016;21:115001.
Abstract Related articles

SUI W, Matulay JT, Onyeji IC, Theofanides MC, et al
Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer.
World J Urol. 2016.
Abstract Related articles

MORALES A
Administration of Mycobacterium phlei cell wall-nucleic acid complex in the immediate postoperative period for the treatment of non-muscle-invasive bladder cancer.
Can Urol Assoc J. 2016;10.
Abstract Related articles

ZLOTTA AR
What's new in bladder cancer research?
Can Urol Assoc J. 2016;10.
Abstract Related articles

MATULEWICZ RS, Frainey BT, Oberlin DT, Meeks JJ, et al
High-Risk of Adverse Pathologic Features in Patients With Clinical T1 High-Grade Bladder Cancer Undergoing Radical Cystectomy.
J Natl Compr Canc Netw. 2016;14:1403-1411.
Abstract Related articles

LEE S, Jang J, Jeon H, Lee J, et al
Latent Kaposi's sarcoma-associated herpesvirus infection in bladder cancer cells promotes drug resistance by reducing reactive oxygen species.
J Microbiol. 2016;54:782-788.
Abstract Related articles

KU JH, Kim WJ, Lerner SP, Chun F, et al
Diagnostic and Prognostic Markers in Bladder Cancer.
Dis Markers. 2016;2016:2425091.
Abstract Related articles

KIM B, Kim G, Song B, Lee C, et al
HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.
Dis Markers. 2016;2016:8463731.
Abstract Related articles

CONCONI D, Sala E, Bovo G, Strada G, et al
Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.
Int J Mol Sci. 2016;17:271.
Abstract Related articles

KHAN M, O'Kane D, Du Plessis J, Hoag N, et al
Primary malignant melanoma of the urinary bladder and ureter.
Can J Urol. 2016;23:8171-5.
Abstract Related articles

PATNE SC, Katiyar R, Chaudhary D, Trivedi S, et al
Dysuria and fever in a young woman diagnosed as having inflammatory myofibroblastic tumour of the urinary bladder.
BMJ Case Rep. 2016;2016.
Abstract Related articles

CUI Y, Chen H, Liu L, Chen J, et al
Comparing the Efficiency and Safety of Bipolar and Monopolar Transurethral Resection for Non-Muscle Invasive Bladder Tumors: A Systematic Review and Meta-Analysis.
J Laparoendosc Adv Surg Tech A. 2016;26:196-202.
Abstract Related articles

PINKERNEIL M, Hoffmann MJ, Deenen R, Kohrer K, et al
Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.
Mol Cancer Ther. 2016;15:299-312.
Abstract Related articles

CHANG HY, Chang TC, Huang WY, Lee CT, et al
RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break-Inducing Anticancer Drugs.
Mol Cancer Ther. 2016;15:276-86.
Abstract Related articles

ERDMANN E, Harding S, Lam H, Perez A, et al
10-Year Observational Follow-Up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes.
Diabetes Obes Metab. 2015 Nov 23. doi: 10.1111/dom.12608.
Abstract Related articles

WANG B, Li X, Ming S, Ma X, et al
Combined Extraperitoneal and Transperitoneal Laparoscopic Extended Partial Cystectomy for the Treatment of Urachal Carcinoma.
J Endourol. 2016;30:280-5.
Abstract Related articles

LI X, Gao Y, Zhou H, Xu W, et al
The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-kappa B1 gene and the risk of urinary cancer.
Cancer Biomark. 2016;16:11-7.
Abstract Related articles

DI TRAPANI E, Sanchez-Salas R, Gandaglia G, Rocchini L, et al
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy.
World J Urol. 2016;34:207-13.
Abstract Related articles

SORIA F, Milla P, Fiorito C, Pisano F, et al
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study.
World J Urol. 2016;34:189-95.
Abstract Related articles

WANG H, Ke C, Ma X, Zhao Q, et al
MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3beta and activating Wnt signaling in bladder cancer cells.
Tumour Biol. 2016.
Abstract Related articles

HU H, Chen Y, Cheng S, Li G, et al
Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.
Wien Klin Wochenschr. 2016.
Abstract Related articles

QUIRT JS, Siemens DR, Zaza K, Mackillop WJ, et al
Patterns of Referral to Radiation Oncology among Patients with Bladder Cancer: a Population-based Study.
Clin Oncol (R Coll Radiol). 2016 Nov 6. pii: S0936-6555(16)30319.
Abstract Related articles

TSUJIMURA N, Yamada NO, Kuranaga Y, Kumazaki M, et al
A Novel Role of Dickkopf-Related Protein 3 in Macropinocytosis in Human Bladder Cancer T24 Cells.
Int J Mol Sci. 2016;17.
Abstract Related articles

RIETHDORF S, Pantel K
Liquid biopsies for surveillance and monitoring treatment response of bladder cancer.
Ann Transl Med. 2016;4:379.
Abstract Related articles

TANIGUCHI Y, Nishikawa H, Karashima T, Yoshinaga Y, et al
Frequency of reactive arthritis, uveitis, and conjunctivitis in Japanese patients with bladder cancer following intravesical BCG therapy: A 20-year, two-centre retrospective study.
Joint Bone Spine. 2016 Nov 4. pii: S1297-319X(16)30169.
Abstract Related articles

SIDAWAY P
Bladder cancer: Autologous NK cells active against high-risk cancer.
Nat Rev Urol. 2016 Nov 8. doi: 10.1038/nrurol.2016.
Abstract Related articles

TAGLIABUE L, Russo G, Lucignani G
18F-FDG PET/CT in Bladder Cancer.
Clin Nucl Med. 2016;41:e522-e524.
Abstract Related articles

GUI-ZHONG L, Li-Bo M
Bladder cancer in individuals with spinal cord injuries: a meta-analysis.
Spinal Cord. 2016 Nov 8. doi: 10.1038/sc.2016.
Abstract Related articles

WEI L, Chintala S, Ciamporcero E, Ramakrishnan S, et al
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
Oncotarget. 2016 Nov 3. doi: 10.18632/oncotarget.13062.
Abstract Related articles

KANG W, Cui Z, Chen Q, Zhang D, et al
Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis.
Oncotarget. 2016 Nov 3. doi: 10.18632/oncotarget.13054.
Abstract Related articles

OHTAKE S, Kawahara T, Kasahara R, Ito H, et al
Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
Biomed Res Int. 2016;2016:9846823.
Abstract Related articles

HANSEN E, Larsson H, Norgaard M, Thind P, et al
The Danish Bladder Cancer Database.
Clin Epidemiol. 2016;8:439-443.
Abstract Related articles

DI MASO M, Bosetti C, Taborelli M, Montella M, et al
Dietary water intake and bladder cancer risk: An Italian case-control study.
Cancer Epidemiol. 2016;45:151-156.
Abstract Related articles

CHEN YJ, Wang HF, Liang M, Zou RC, et al
Upregulation of miR-3658 in bladder cancer and tumor progression.
Genet Mol Res. 2016;15.
Abstract Related articles

RADY EA, Hassanein WA, Elhaddad TA
The power Lomax distribution with an application to bladder cancer data.
Springerplus. 2016;5:1838.
Abstract Related articles

ZHOU TC, Sankin AI, Porcelli SA, Perlin DS, et al
A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.
Urol Oncol. 2016 Nov 2. pii: S1078-1439(16)30309.
Abstract Related articles

BOULANGER M, Tual S, Lemarchand C, Guizard AV, et al
Agricultural exposure and risk of bladder cancer in the AGRIculture and CANcer cohort.
Int Arch Occup Environ Health. 2016.
Abstract Related articles

ZHOU M, Wang S, Hu L, Liu F, et al
miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7.
BMC Urol. 2016;16:64.
Abstract Related articles

VERRILLI AM, Hohenhaus AE, Le Roux AB, Donovan TA, et al
What Is Your Diagnosis?: Primary pulmonary neoplasia.
J Am Vet Med Assoc. 2016;248:493-6.
Abstract Related articles

PAPADIMITRIOU JC, Randhawa P, Rinaldo CH, Drachenberg CB, et al
BK Polyomavirus Infection and Renourinary Tumorigenesis.
Am J Transplant. 2016;16:398-406.
Abstract Related articles

SAMARATUNGA H, Delahunt B, Egevad L, Adamson M, et al
Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation.
Histopathology. 2016;68:533-40.
Abstract Related articles

HUANG K, Chen G, Li Y, Liu JK, et al
[Expression of PAK1 in bladder cancer and its influence on invasion of bladder cancer cells].
Zhonghua Yi Xue Za Zhi. 2016;96:3227-3231.
Abstract Related articles

PANDYA S, Sutaria J
1809: FOOTDROP AS A HARBINGER OF METASTATIC BLADDER CANCER.
Crit Care Med. 2016;44.
Abstract Related articles

OCHOA AE, Choi W, Su X, Siefker-Radtke A, et al
Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
Oncotarget. 2016 Nov 10. doi: 10.18632/oncotarget.13284.
Abstract Related articles

STEINBERG GD
Bladder cancer: Assessing the conundrum of microscopic haematuria.
Nat Rev Urol. 2016 Nov 15. doi: 10.1038/nrurol.2016.
Abstract Related articles

ITAM S, Elhage O, Khan MS
Large leiomyoma of the bladder masquerading as an enlarged prostate gland.
BMJ Case Rep. 2016;2016.
Abstract Related articles

KIM KH, Kabir E, Jahan SA
The use of personal hair dye and its implications for human health.
Environ Int. 2016;89-90:222-7.
Abstract Related articles

BUISSON Y
[Congres de la Societe de pathologie exotique : parasitoses, mycoses et cancer 18 novembre 2015, Institut Pasteur, Paris].
Bull Soc Pathol Exot. 2016;109:46-50.
Abstract Related articles

YOSHIKAWA H, Nolan MW, Lewis DW, Larue SM, et al
RETROSPECTIVE EVALUATION OF INTERFRACTION URETERAL MOVEMENT IN DOGS UNDERGOING RADIATION THERAPY TO ELUCIDATE APPROPRIATE SETUP MARGINS.
Vet Radiol Ultrasound. 2016;57:170-9.
Abstract Related articles

CECI C, Tentori L, Atzori MG, Lacal PM, et al
Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
Nutrients. 2016;8.
Abstract Related articles

ZHANG Z, Zhang G, Kong C
Targeted inhibition of Polo-like kinase 1 by a novel small-molecule inhibitor induces mitotic catastrophe and apoptosis in human bladder cancer cells.
J Cell Mol Med. 2016 Nov 23. doi: 10.1111/jcmm.13018.
Abstract Related articles

DONG L, Lin F, Wu W, Huang W, et al
Transcriptional cofactor Mask2 is required for YAP-induced cell growth and migration in bladder cancer cell.
J Cancer. 2016;7:2132-2138.
Abstract Related articles

FUNT SA, Rosenberg JE
Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.
Nat Rev Clin Oncol. 2016 Nov 22. doi: 10.1038/nrclinonc.2016.
Abstract Related articles

VAN HOOREN L, Sandin LC, Moskalev I, Ellmark P, et al
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer.
Eur J Immunol. 2016 Nov 22. doi: 10.1002/eji.201646583.
Abstract Related articles

HOSSEINI SA, Zanganeh S, Akbarnejad E, Salehi F, et al
Microfluidic device for label-free quantitation and distinction of bladder cancer cells from the blood cells using micro machined silicon based electrical approach; suitable in urinalysis assays.
J Pharm Biomed Anal. 2016;134:36-42.
Abstract Related articles

Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86.
Int J Radiat Oncol Biol Phys. 2016;96:1129.
Abstract Related articles

URQUIDI V, Netherton M, Gomes-Giacoia E, Serie DJ, et al
A microRNA biomarker panel for the non-invasive detection of bladder cancer.
Oncotarget. 2016 Nov 16. doi: 10.18632/oncotarget.13382.
Abstract Related articles

WANG H, Niu L, Jiang S, Zhai J, et al
Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
Oncotarget. 2016 Nov 15. doi: 10.18632/oncotarget.13363.
Abstract Related articles

CHEN X, Gu P, Xie R, Han J, et al
Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.
J Cell Mol Med. 2016 Nov 10. doi: 10.1111/jcmm.12999.
Abstract Related articles

TOKAS T, Avgeris M, Alamanis C, Scorilas A, et al
Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.
J Cancer Res Clin Oncol. 2016.
Abstract Related articles

YU C, Hequn C, Longfei L, Long W, et al
GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.
Oncotarget. 2016 Nov 29. doi: 10.18632/oncotarget.13702.
Abstract Related articles

SORIA F, Moschini M, Abufaraj M, Wirth GJ, et al
Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer.
Urol Oncol. 2016 Nov 28. pii: S1078-1439(16)30362.
Abstract Related articles

WANG X, Liang Z, Xu X, Li J, et al
miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
Cell Death Dis. 2016;7:e2503.
Abstract Related articles

NAN YH, Wang J, Wang Y, Sun PH, et al
MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.
Am J Transl Res. 2016;8:4892-4901.
Abstract Related articles

HUANG B, Zhai W, Hu G, Huang C, et al
MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.
Am J Transl Res. 2016;8:4705-4715.
Abstract Related articles

NOUHAUD FX, Rigaud J, Saint F, Colombel M, et al
Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancer.
Anticancer Drugs. 2016.
Abstract Related articles

HOU L, Hong X, Dai M, Chen P, et al
Association of smoking status with prognosis in bladder cancer: A meta-analysis.
Oncotarget. 2016 Nov 25. doi: 10.18632/oncotarget.13606.
Abstract Related articles

DING C, Wu K, Wang W, Guan Z, et al
Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13578.
Abstract Related articles

MENDEZ WM JR, Eftim S, Cohen J, Warren I, et al
Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
J Expo Sci Environ Epidemiol. 2016 Nov 30. doi: 10.1038/jes.2016.
Abstract Related articles

LAZARO M, Gallardo E, Domenech M, Pinto A, et al
SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
Clin Transl Oncol. 2016.
Abstract Related articles

VU VAN D, Heberling U, Wirth MP, Fuessel S, et al
Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer.
Oncol Lett. 2016;12:3143-3152.
Abstract Related articles

ARAFAT W, Darwish A, Naoum GE, Sameh W, et al
Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients.
Ecancermedicalscience. 2016;10:682.
Abstract Related articles

SRIVASTAVA AK, Singh PK, Singh D, Dalela D, et al
Clinical utility of urinary soluble Fas in screening for bladder cancer.
Asia Pac J Clin Oncol. 2016;12:e215-21.
Abstract Related articles

YAMASHITA H, Amponsa VO, Warrick JI, Zheng Z, et al
On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer.
Nat Rev Urol. 2016 Nov 29. doi: 10.1038/nrurol.2016.
Abstract Related articles

KANIGEL WINNER KR, Costello JC
A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG.
Pac Symp Biocomput. 2016;22:611-622.
Abstract Related articles

KOJIMA T, Kawai K, Miyazaki J, Nishiyama H, et al
Biomarkers for precision medicine in bladder cancer.
Int J Clin Oncol. 2016.
Abstract Related articles

ZHANG N, Jiang G, Liu X, Na R, et al
Prediction of Bacillus Calmette-Guerin Response in Patients with Bladder Cancer after Transurethral Resection of Bladder Tumor by Using Genetic Variation Based on Genomic Studies.
Biomed Res Int. 2016;2016:9859021.
Abstract Related articles

KATO T, Yasuda K, Iida H, Watanabe A, et al
Trousseau's syndrome caused by bladder cancer producing granulocyte colony-stimulating factor and parathyroid hormone-related protein: A case report.
Oncol Lett. 2016;12:4214-4218.
Abstract Related articles

EGLOFF SA, Du L, Loomans HA, Starchenko A, et al
Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13546.
Abstract Related articles

XIANG W, Wu X, Huang C, Wang M, et al
PTTG1 regulated by miR-146-3p promotes bladder cancer migration, invasion, metastasis and growth.
Oncotarget. 2016 Nov 22. doi: 10.18632/oncotarget.13507.
Abstract Related articles

ZHANG X, Yang X, Yang C, Li P, et al
Targeting protein kinase CK2 suppresses bladder cancer cell survival via the glucose metabolic pathway.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13571.
Abstract Related articles

HAHN NM
New treatments for bladder cancer.
Clin Adv Hematol Oncol. 2016;14:884-887.
Abstract Related articles

WARRICK JI, Walter V, Yamashita H, Chung E, et al
FOXA1, GATA3 and PPAR Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
Sci Rep. 2016;6:38531.
Abstract Related articles

SELINSKI S, Burger H, Blaszkewicz M, Otto T, et al
Occupational risk factors for relapse-free survival in bladder cancer patients.
J Toxicol Environ Health A. 2016;79.
Abstract Related articles

YU GQ, Dou ZL, Jia ZH
5bromo3(3hydroxyprop1ynyl)2Hpyran2one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways.
Mol Med Rep. 2016 Dec 6. doi: 10.3892/mmr.2016.5991.
Abstract Related articles

AKAZA H
Bladder cancer: Advancing NMIBC treatment beyond current BCG formulations.
Nat Rev Urol. 2016 Dec 6. doi: 10.1038/nrurol.2016.
Abstract Related articles

CHIU HF, Chen BK, Yang CY
Parity, Age at First Birth, and Risk of Death from Bladder Cancer: A Population-Based Cohort Study in Taiwan.
Int J Environ Res Public Health. 2016;13.
Abstract Related articles

KOPSIAFTIS S, Hegde P, Taylor JA 3rd, Claffey KP, et al
AMPKalpha Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.
Transl Oncol. 2016;9:606-616.
Abstract Related articles

LI HT, Duymich CE, Weisenberger DJ, Liang G, et al
Genetic and Epigenetic Alterations in Bladder Cancer.
Int Neurourol J. 2016;20.
Abstract Related articles

MARTINI A, Villari D, Nicita G
Editorial comment to: Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis.
Int J Surg. 2016 Nov 29. pii: S1743-9191(16)31148.
Abstract Related articles

TERRERI S, Durso M, Colonna V, Romanelli A, et al
New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer.
Genes (Basel). 2016;7.
Abstract Related articles

HONG Z, Li H, Li L, Wang W, et al
Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
Cancer Biomark. 2016.
Abstract Related articles

KOIE T, Ohyama C, Yamamoto H, Imai A, et al
The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
Jpn J Clin Oncol. 2016.
Abstract Related articles

SAHU D, Gupta S, Hau AM, Nakashima K, et al
Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2alpha Activity and Is Targetable by Pegylated Arginine Deiminase.
Am J Pathol. 2016 Dec 9. pii: S0002-9440(16)30407.
Abstract Related articles

YANG R, Liu M, Liang H, Guo S, et al
miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
Mol Cancer. 2016;15:82.
Abstract Related articles

ANGHEL RM, Gales LN, Trifanescu OG
Outcome of urinary bladder cancer after combined therapies.
J Med Life. 2016;9:95-100.
Abstract Related articles

ZHOU Y, Chan CF, Kwong DW, Law GL, et al
alphavbeta3-Isoform specific erbium complexes highly specific for bladder cancer imaging and photodynamic therapy.
Chem Commun (Camb). 2016.
Abstract Related articles

HEIDEGGER I, Oberaigner W, Horninger W, Pichler R, et al
High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience.
Urol Oncol. 2016 Dec 9. pii: S1078-1439(16)30370.
Abstract Related articles

HUGEN CM, Duddalwar V, Daneshmand S
Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy.
Curr Urol Rep. 2016;17:62.
Abstract Related articles

WINNENBURG R, Shah NH
Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature.
BMC Bioinformatics. 2016;17:250.
Abstract Related articles

LIM S, Koh MJ, Jeong HJ, Cho NH, et al
Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
Yonsei Med J. 2016;57:831-9.
Abstract Related articles

ARTCIBASOVA AV, Korzinkin MB, Sorokin MI, Shegay PV, et al
MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways.
Cell Cycle. 2016;15:689-98.
Abstract Related articles

LIU S, Zou L, Mao S, Zhang L, et al
The safety and efficacy of bladder cryoablation in a beagle model by using a novel balloon cryoprobe.
Cryobiology. 2016;72:157-60.
Abstract Related articles

UESHIMA H, Myint KZ, Otake H
Detection of large perforating artery by ultrasound prescan before obturator nerve block.
J Clin Anesth. 2016;29:14.
Abstract Related articles

ROMAN-JIMENEZ G, Crevoisier RD, Leseur J, Devillers A, et al
Detection of bladder metabolic artifacts in (18)F-FDG PET imaging.
Comput Biol Med. 2016;71:77-85.
Abstract Related articles

NECCHI A, Lo Vullo S, Mariani L, Raggi D, et al
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer.
Invest New Drugs. 2016;34:236-42.
Abstract Related articles

KUBOTA H, Takahashi S, Monzawa S, Yuasa N, et al
Pictorial review of orthotopic neobladder reconstruction: indication, normal postsurgical anatomy, and complications.
Abdom Radiol (NY). 2016;41:356-67.
Abstract Related articles

MORGAN MS, Antonelli JA, Lotan Y, Shakir N, et al
Use of an Electronic Medical Record to Assess Patient-Reported Morbidity Following Ureteroscopy.
J Endourol. 2016;30 Suppl 1:S46-51.
Abstract Related articles

NADEEM H, Jayakrishnan TT, Rajeev R, Johnston FM, et al
Cost Differential of Chemotherapy for Solid Tumors.
J Oncol Pract. 2016;12:e299-307.
Abstract Related articles

PANER GP, Lopez-Beltran A, Sirohi D, Amin MB, et al
Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
Adv Anat Pathol. 2016;23:71-83.
Abstract Related articles

ZENG X, Xu Z, Gu J, Huang H, et al
Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.
Mol Cancer Ther. 2016;15:512-22.
Abstract Related articles

BALL MW, Nathan R, Gerayli F
Long-Term Response After Surgery and Adjuvant Chemoradiation for T4 Mucinous Adenocarcinoma of the Bladder: A Case Report and Review of the Literature.
Clin Genitourin Cancer. 2016;14:e225-7.
Abstract Related articles

RETZ M, Gschwend JE, Schmid SC
[Update 2016 - Immunotherapy for urothelial carcinoma].
Urologe A. 2016;55:246-52.
Abstract Related articles

BIENTINESI R, Ragonese M, Pinto F, Bassi PF, et al
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review.
Clin Genitourin Cancer. 2016;14:e199-201.
Abstract Related articles

VALLONTHAIEL AG, Kaur K, Jain D, Singh G, et al
Ewing Sarcoma of Urinary Bladder Showing EWSR1 Rearrangement on FISH Analysis and Unique Response to Chemotherapy.
Clin Genitourin Cancer. 2016;14:e183-6.
Abstract Related articles

DE SANTIS M, Wiechno PJ, Bellmunt J, Lucas C, et al
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1).
Ann Oncol. 2016;27:449-54.
Abstract Related articles

GOLDBERG H, Baniel J, Mano R, Rotlevy G, et al
Orthotopic neobladder vs. ileal conduit urinary diversion: A long-term quality-of-life comparison.
Urol Oncol. 2016;34:121.
Abstract Related articles

CAPOGROSSO P, Capitanio U, Ventimiglia E, Boeri L, et al
Detrusor Muscle in TUR-Derived Bladder Tumor Specimens: Can We Actually Improve the Surgical Quality?
J Endourol. 2016;30:400-5.
Abstract Related articles

MAEBAYASHI T, Ishibashi N, Aizawa T, Sakaguchi M, et al
Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients.
Anticancer Res. 2016;36:4763-9.
Abstract Related articles

CHANG WS, Liao CH, Tsai CW, Hu PS, et al
Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.
Anticancer Res. 2016;36:4509-14.
Abstract Related articles

SAKAGUCHI M, Maebayashi T, Aizawa T, Ishibashi N, et al
Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy.
Anticancer Res. 2016;36:5519-5525.
Abstract Related articles

KRIEGMAIR MC, Balk M, Wirtz R, Steidler A, et al
Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer.
Anticancer Res. 2016;36:5205-5213.
Abstract Related articles

FERNANDEZ MI, Williams SB, Willis DL, Slack RS, et al
Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer.
BJU Int. 2016 Oct 18. doi: 10.1111/bju.13689.
Abstract Related articles

ALJABERY F, Shabo I, Olson H, Gimm O, et al
Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer-a prospective clinical study.
BJU Int. 2016 Oct 31. doi: 10.1111/bju.13700.
Abstract Related articles

PARDINI B, Viberti C, Naccarati A, Allione A, et al
Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer.
Br J Cancer. 2016 Dec 13. doi: 10.1038/bjc.2016.
Abstract Related articles

OJERHOLM E, Smith A, Hwang WT, Baumann BC, et al
Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
Cancer. 2016 Oct 27. doi: 10.1002/cncr.30422.
Abstract Related articles

INMAN BA, Longo TA, Ramalingam S, Harrison MR, et al
Atezolizumab: a PD-L1 blocking antibody for bladder cancer.
Clin Cancer Res. 2016 Nov 30. pii: clincanres.1417.2016.
Abstract Related articles

CHOPRA S, Abreu AL, Gill IS
Robotic urinary diversion: the range of options.
Curr Opin Urol. 2016;26:107-13.
Abstract Related articles

LIEM EI, de Reijke TM
Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer?
Curr Opin Urol. 2016.
Abstract Related articles

GOOSSENS ME, Zeegers MP, van Poppel H, Joniau S, et al
Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial.
Eur J Cancer. 2016;69:9-18.
Abstract Related articles

HERMANS TJ, Fransen van de Putte EE, Horenblas S, Meijer RP, et al
Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
Eur J Cancer. 2016;69:1-8.
Abstract Related articles

VAN DER HEIJDEN AG, Mengual L
Reply to letter commenting on: A five-gene expression signature to predict progression in T1G3 bladder cancer.
Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32449.
Abstract Related articles

ORSOLA A, Mullane SA, Bellmunt J
Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernandez PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer
Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32448.
Abstract Related articles

LUO HL, Chen YT, Cheng YT, Chiang PH, et al
Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Can
Eur Urol. 2016 Sep 26. pii: S0302-2838(16)30663.
Abstract Related articles

SEISEN T, Babjuk M, Roupret M
Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang's Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for
Eur Urol. 2016 Sep 22. pii: S0302-2838(16)30662.
Abstract Related articles

SATKUNASIVAM R, Santomauro M, Chopra S, Plotner E, et al
Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life.
Eur Urol. 2016;69:247-53.
Abstract Related articles

KAMAT AM, Briggman J, Urbauer DL, Svatek R, et al
Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guerin.
Eur Urol. 2016;69:197-200.
Abstract Related articles

SYLVESTER RJ, Oosterlinck W, Holmang S, Sydes MR, et al
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carci
Eur Urol. 2016;69:231-44.
Abstract Related articles

NECCHI A, Giardiello D, Mariani L
Methodological Considerations for Early-phase Development of Immune Checkpoint Inhibitors in Urothelial Bladder Cancer.
Eur Urol. 2016 Oct 6. pii: S0302-2838(16)30684.
Abstract Related articles

LIEDBERG F, Jancke G, Sorenby A, Kannisto P, et al
Should we Refrain from Performing Oophorectomy in Conjunction with Radical Cystectomy for Bladder Cancer?
Eur Urol. 2016 Oct 19. pii: S0302-2838(16)30713.
Abstract Related articles

PICKARD R
Is Robot-assisted Cystectomy Better than Open?--Nearing an Answer after a Decade of Use.
Eur Urol. 2016;69:622-3.
Abstract Related articles

HAMILTON-REEVES JM, Bechtel MD, Hand LK, Schleper A, et al
Effects of Immunonutrition for Cystectomy on Immune Response and Infection Rates: A Pilot Randomized Controlled Clinical Trial.
Eur Urol. 2016;69:389-92.
Abstract Related articles

KAMEYAMA K, Horie K, Mizutani K, Kato T, et al
Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression.
Int J Oncol. 2016 Nov 24. doi: 10.3892/ijo.2016.3781.
Abstract Related articles

WANG JP, Jiao Y, Wang CY, Xu ZB, et al
Rb knockdown accelerates bladder cancer progression through E2F3 activation.
Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3791.
Abstract Related articles

CHEN L, Wang G, Luo Y, Wang Y, et al
Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
Int J Oncol. 2016 Dec 5. doi: 10.3892/ijo.2016.3788.
Abstract Related articles

HERMANS TJ, van de Putte EE, Horenblas S, van Rhijn BW, et al
Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study.
Int J Urol. 2016 Oct 4. doi: 10.1111/iju.13227.
Abstract Related articles

REIS LO
Editorial Comment to Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.
Int J Urol. 2016;23:963.
Abstract Related articles

VIDAL A, Arnold N, Vartolomei MD, Kiss B, et al
Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.
Int J Urol. 2016 Oct 21. doi: 10.1111/iju.13228.
Abstract Related articles

BESIROGLU H
Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
Int J Urol. 2016 Dec 1. doi: 10.1111/iju.13269.
Abstract Related articles

MAURICE MJ, Kim SP, Abouassaly R
Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer.
Int Urol Nephrol. 2016.
Abstract Related articles

LI HM, Azhati B, Rexiati M, Wang WG, et al
Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
Int Urol Nephrol. 2016.
Abstract Related articles

MAY M, Protzel C, Vetterlein MW, Gierth M, et al
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
Int Urol Nephrol. 2016.
Abstract Related articles

ATALA A
Re: Regulation of UHRF1 by Dual-Strand Tumor-Suppressor MicroRNA-145 (miR-145-5p and miR-145-3p): Inhibition of Bladder Cancer Cell Aggressiveness.
J Urol. 2016;196:1314.
Abstract Related articles

CHANG SS
Re: Investigation of Multisequence Magnetic Resonance Imaging for Detection of Recurrent Tumor after Transurethral Resection for Bladder Cancer.
J Urol. 2016;196:1045.
Abstract Related articles

CHANG SS
Re: Quality of Life in Patients with Non-Muscle-Invasive Bladder Cancer: One-Year Results of a Multicentre Prospective Cohort Study.
J Urol. 2016;196:1045-6.
Abstract Related articles

CHANG SS
Re: Gene Expression Test for the Non-Invasive Diagnosis of Bladder Cancer: A Prospective, Blinded, International and Multicenter Validation Study.
J Urol. 2016;196:1044-6.
Abstract Related articles

CHOU R, Selph S, Buckley DI, Fu R, et al
Comparative effectiveness of fluorescent versus white light cystoscopy for initial diagnosis or surveillance of bladder cancer on clinical outcomes: Systematic review and meta-analysis.
J Urol. 2016 Oct 22. pii: S0022-5347(16)31585-3. doi: 10.1016/j.juro.2016.
Abstract Related articles

CHANG SS
Re: Long-Term Follow-up of TaG1 Non-Muscle-Invasive Bladder Cancer.
J Urol. 2017;197:52-54.
Abstract Related articles

WANG DS
Re: Long-Term Changes in Renal Function Outcomes following Radical Cystectomy and Urinary Diversion.
J Urol. 2016;195:1511.
Abstract Related articles

MOREY AF
Re: Outcomes of the Endoscopic Treatment of Bladder Neck Contractures in the Orthotopic Neobladder.
J Urol. 2016;195:1508-9.
Abstract Related articles

CHANG SS
Re: Oncologic Outcomes following Robot-Assisted Radical Cystectomy with Minimum 5-Year Follow-up: The Roswell Park Cancer Institute Experience.
J Urol. 2016;195:1381-2.
Abstract Related articles

VENKATRAMANI V, Parekh DJ
Editorial Comment.
J Urol. 2016;195:1375.
Abstract Related articles

KRISHNAN N, Liu X, Lavieri MS, Hu M, et al
A Model to Optimize Followup Care and Reduce Hospital Readmissions after Radical Cystectomy.
J Urol. 2016;195:1362-7.
Abstract Related articles

ZHANG H, Ye YL, Li MX, Ye SB, et al
CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
Oncogene. 2016 Oct 10. doi: 10.1038/onc.2016.
Abstract Related articles

COCCIA A, Mosca L, Puca R, Mangino G, et al
Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.
Oncol Rep. 2016 Oct 5. doi: 10.3892/or.2016.5150.
Abstract Related articles

VARINOT J, Furudoi A, Roupret M, Comperat E, et al
[Update on molecular classifications and new histological classification of bladder cancer].
Prog Urol. 2016 Sep 20. pii: S1166-7087(16)30419.
Abstract Related articles

IRANI J
[Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
Prog Urol. 2016 Oct 3. pii: S1166-7087(16)30564.
Abstract Related articles

DABI Y, Rouscoff Y, Delongchamps NB, Sibony M, et al
[Negative prognostic impact of female gender on oncological outcomes following radical cystectomy].
Prog Urol. 2016;26:83-8.
Abstract Related articles

ROUPRET M, Neuzillet Y, Masson-Lecomte A, Colin P, et al
[CCAFU french national guidelines 2016-2018 on bladder cancer].
Prog Urol. 2016;27 Suppl 1:S67-S91.
Abstract Related articles

D'ELIA C, Comploj E, Cerruto MA, Trenti E, et al
90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series.
Urol Int. 2016.
Abstract Related articles

SHIVAPPA N, Hebert JR, Rosato V, Rossi M, et al
Dietary Inflammatory Index and Risk of Bladder Cancer in a Large Italian Case-Control Study.
Urology. 2016 Sep 29. pii: S0090-4295(16)30637.
Abstract Related articles

ANANTHARAMAN A, Friedlander T, Lu D, Krupa R, et al
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
BMC Cancer. 2016;16:744.
Abstract Related articles

BENHAMOU S, Bonastre J, Groussard K, Radvanyi F, et al
A prospective multicenter study on bladder cancer: the COBLAnCE cohort.
BMC Cancer. 2016;16:837.
Abstract Related articles

KONG C, Zhan B, Piao C, Zhang Z, et al
Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice.
BMC Cancer. 2016;16:892.
Abstract Related articles

GARCIA MM, Gottschalk AR, Brajtbord J, Konety BR, et al
Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes.
PLoS One. 2016;11:e0164558.
Abstract Related articles

XIE J, Codd C, Mo K, He Y, et al
Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
PLoS One. 2016;11:e0164792.
Abstract Related articles

KIM D, Choi Y, Ireland J, Foreman O, et al
Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers.
PLoS One. 2016;11:e0165856.
Abstract Related articles

LIMA L, Gaiteiro C, Peixoto A, Soares J, et al
Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies.
PLoS One. 2016;11:e0166120.
Abstract Related articles

LONG X, Zu X, Li Y, He W, et al
Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy.
PLoS One. 2016;11:e0166884.
Abstract Related articles

DAI L, Ma C, Zhang Z, Zeng S, et al
DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
PLoS One. 2016;11:e0167228.
Abstract Related articles

KANEMOTO K, Fukuta K, Kawai N, Tozawa K, et al
Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.
PLoS One. 2016;11:e0167374.
Abstract Related articles

WU Z, Wang C, Zhang Z, Liu W, et al
High Expression of Derlin-1 Is Associated with the Malignancy of Bladder Cancer in a Chinese Han Population.
PLoS One. 2016;11:e0168351.
Abstract Related articles

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:

;